Skip to main content
Clinical Trials/ISRCTN16062949
ISRCTN16062949
Active, not recruiting
未知

Evaluation of a novel multi-component anxiety management programme: a mixed methods quasi-experimental feasibility study

Cheshire and Wirral Partnership NHS Foundation Trust0 sites60 target enrollmentJuly 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cheshire and Wirral Partnership NHS Foundation Trust
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37730412/ (added 21/09/2023)

Registry
who.int
Start Date
July 31, 2023
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cheshire and Wirral Partnership NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants aged over 18 years of age.
  • 2\. Registered diagnosis of mild or moderate intellectual disability with or without autism.
  • 3\. Scores above seven (range 7\-18\) on the anxiety component on the MOSS Pas\-ID (Moss et al., 1998\).
  • 4\. Required to provide informed consent and sign a declaration form indicating agreement to participate.

Exclusion Criteria

  • 1\. If they choose not to be involved in the study.
  • 2\. Have a severe or profound intellectual disability.
  • 3\. Lack capacity to consent.
  • 4\. Under the age of 18 years old.
  • 5\. Participants who score below 7 on the anxiety component of the Moss PAS\-ID.

Outcomes

Primary Outcomes

Not specified

Similar Trials